Radiation-induced gliomas in 2 pediatric patients with neurofibromatosis type 1: Case study and summary of the literature

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 2, 2014, Pages

  Madden, Jennifer R ^a   Rush, Sarah Z ^a   Stence, Nicholas ^a   Foreman, Nicholas K ^a   Liu, Arthur K ^b  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

glioblastoma; Neurofibromatosis type 1; radiation

Indexed keywords

CARBOPLATIN; VINCRISTINE;

ARTICLE; ASTROCYTOMA; ATAXIA; BRAIN STEM TUMOR; BRAIN SURGERY; CANCER RADIOTHERAPY; CASE REPORT; CHILD; CRANIAL NERVE PARALYSIS; CRANIOTOMY; CYTOREDUCTIVE SURGERY; GLIOMA; HEADACHE; HEMIPARESIS; HUMAN; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION INDUCED NEOPLASM; SCHOOL CHILD; SOMNOLENCE; TRACHEOSTOMY; TUMOR BIOPSY;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; GLIOMA; HUMANS; NEOPLASMS, RADIATION-INDUCED; NEUROFIBROMATOSIS 1;

EID: 84896718931     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000006     Document Type: Article

References (31)

1. Listernick R, Charrow J, Greenwald M, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125:63-66.
2. Listernick R, Charrow J, Greenwald MJ, et al. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. 1989;114: 788-792.
3. Hernaiz Driever P, von Hornstein S, Pietsch T, et al. Natural history and management of low-grade glioma in NF-1 children. J Neurooncol. 2010;100:199-207.
4. Wentworth S, Pinn M, Bourland JD, et al. Clinical experience with radiation therapy in the management of neurofibromatosis- associated central nervous system tumors. Int J Radiat Oncol Biol Phys. 2009;73:208-213.
5. Sharif S, Ferner R, Birch JM, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol. 2006;24: 2570-2575.
6. Ducatman BS, Scheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57:2006-2021.
7. Matsui I, Tanimura M, Kobayashi N, et al. Neurofibromatosis type 1 and childhood cancer. Cancer. 1993;72:2746-2754.
8. Loree TR, North JH Jr., Werness BA, et al. Malignant peripheral nerve sheath tumors of the head and neck: analysis of prognostic factors. Otolaryngol Head Neck Surg. 2000;122: 667-672.
9. Torricelli P, Guarneri AG, Romani F, et al. Malignant schwannoma associated with von Recklinghausen's disease. Report of a case following radiation therapy. Rays. 1985;10: 127-131.
10. Foley KM, Woodruff JM, Ellis FT, et al. Radiation-induced malignant and atypical peripheral nerve sheath tumors. Ann Neurol. 1980;7:311-318.
11. Sordillo PP, Helson L, Hajdu SI, et al. Malignant schwannoma- clinical characteristics, survival, and response to therapy. Cancer. 1981;47:2503-2509.
12. Chowdhry M, Hughes C, Grimer RJ, et al. Bone sarcomas arising in patients with neurofibromatosis type 1. J Bone Joint Surg Br. 2009;91:1223-1226.
13. Corkill AG, Ross CF. A case of neurofibromatosis complicated by medulloblastoma, neurogenic sarcoma, and radiationinduced carcinoma of thyroid. J Neurol Neurosurg Psychiatry. 1969;32:43-47.
14. Carret AS, Tabori U, Crooks B, et al. Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium. Radiother Oncol. 2006;81:33-38.
15. Jamjoom AB, Malabarey T, Jamjoom ZA, et al. Cerebrovasculopathy and malignancy: catastrophic complications of radiotherapy for optic nerve glioma in a von Recklinghausen neurofibromatosis patient. Neurosurg Rev. 1996;19:47-51.
16. Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27:2356-2362.
17. Neglia JP, Robison LL, Stovall M, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98:1528-1537.
18. Garwicz S, Anderson H, Olsen JH, et al. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries. Int J Cancer. 2000;88:672-678.
19. Olsen JH, Garwicz S, Hertz H, et al. Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ. 1993;307:1030-1036.
20. Heymann S, Delaloge S, Rahal A, et al. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol. 2010; 5:104.
21. Grill J, Couanet D, Cappelli C, et al. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol. 1999;45:393-396.
22. Brat DJ, James CD, Jedlicka AE, et al. Molecular genetic alterations in radiation-induced astrocytomas. Am J Pathol. 1999;154:1431-1438.
23. Donson AM, Erwin NS, Kleinschmidt-DeMasters BK, et al. Unique molecular characteristics of radiation-induced glioblastoma. J Neuropathol Exp Neurol. 2007;66:740-749.
24. Pascual-Castroviejo I, Pascual-Pascual SI, Viano J, et al. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst. 2010;26:1599-1603.
25. Martinez-Lage JF. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst. 2010;26: 1491, author reply 1493.
26. Paulino AC, Mai WY, Chintagumpala M, et al. Radiationinduced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys. 2008;71:1381-1387.
27. Bouffet E, Jakacki R, Goldman S, et al. Phase II study of weekly vinblastine in recurrent or refractory pediatric lowgrade glioma. J Clin Oncol. 2012;30:1358-1363.
28. Thorarinsdottir HK, Santi M, McCarter R, et al. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. Clin Cancer Res. 2008;14:3386-3394.
29. Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118: 1739-1749.
30. Tatevossian RG, Lawson AR, Forshew T, et al. MAPK pathway activation and the origins of pediatric low-grade astrocytomas. J Cell Physiol. 2010;222:509-514.
31. Yalon M, Rood B, MacDonald TJ, et al. A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG). Pediatr Blood Cancer. 2013;60:71-76.